• Profile
Close

Use of supplementary patient education material increases treatment adherence and satisfaction among acne patients receiving adapalene 0.1%/benzoyl peroxide 2.5% gel in primary care clinics: A multicenter, randomized, controlled clinical study

Dermatology and Therapy Oct 17, 2017

Myhill T, et al. - This study strived to gauge the consequence of supplementary patient education material (SEM) (a short video, information card, and additional information available online) on the treatment adherence and satisfaction among acne patients treated with the fixed-dose combination adapalene 0.1%/benzoyl peroxide 2.5% gel (A/BPO) in primary care clinics. The yielded findings were compared with (1) standard-of-care patient education (SOCPE) (package insert and oral instruction) and (2) SOCPE plus more frequent clinic visits. A rise in the adherence of acne patients treated with once-daily A/BPO gel could be achieved via SEM, in the primary care. This, in turn, improved the treatment and quality of life (QoL), in the long term.

Methods

  • The enrollees with acne were randomized to receive once-daily A/BPO for 12 weeks plus (1) SEM in addition to SOCPE; (2) SOCPE only with two additional visits; or (3) SOCPE only.
  • Additional analyses comprised of a subject appreciation questionnaire, a physician questionnaire, and safety.

Results

  • This study recruited 97 subjects. At baseline, most (87.6%) patients reported mild to moderate acne.
  • The A/BPO + SEM group displayed better adherence compared with A/BPO + more visits or A/BPO alone [mean 63.1%, 48.2% (p = 0.0206), and 56.5%, respectively].
  • The A/BPO + SEM group constituted more individuals with greater than 75% adherence (45%, 30.4%, and 25%, respectively).
  • The SEM was more beneficial to adhere to treatment (56.7%) versus more visits (32.3%) and A/BPO alone (15.2%), better use the product (70%, 61.3%, and 54.5%, respectively), and better manage skin irritation (53.3%, 48.4%, and 36.4%, respectively), based on the subject appreciation questionnaire.
  • Satisfaction was found among all physicians with the SEM and 90% would consider its utility in their practice.
  • Safety assessment illustrated fewer treatment-related adverse events in the A/BPO + SEM group.

Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay